Scientists Develop First Personalized CRISPR Gene Therapy for Rare Genetic Disorder
A custom-designed treatment successfully corrected a life-threatening mutation in an infant, marking a new era in precision medicine.


PENN Explainer
Hear this story explained in 90 seconds.
Medical researchers have achieved a significant milestone in genetic medicine by successfully treating a rare disorder using a therapy designed specifically for a single patient. The breakthrough involved an infant named KJ Muldoon, who was born with a rare gene mutation that prevented his body from processing ammonia correctly. This condition caused dangerous levels of the substance to build up, posing an immediate threat to his life. Doctors at the Children's Hospital of Philadelphia utilized a custom CRISPR-based gene therapy to address the underlying cause of the illness.
This approach marked the first time scientists have created a treatment tailored entirely to the unique genetic makeup of one individual. By erasing the specific mutation and inserting a corrected sequence, the team was able to stabilize the baby's health. The success of this procedure has provided new hope for families dealing with rare genetic conditions that previously lacked effective treatment options. Following the intervention, the young patient has shown remarkable progress, including reaching developmental milestones such as learning to walk.
Researchers noted that the procedure’s success serves as a major proof of concept for the future of CRISPR technology. While the patient will require ongoing monitoring, the treatment has significantly reduced his reliance on other medications and improved his overall quality of life. Experts believe this personalized method could eventually be adapted to help other individuals suffering from rare diseases. A new clinical trial is currently in the works to explore how this approach might be applied more broadly.
This development highlights the growing potential of precision medicine to address health challenges that were once considered untreatable. As the field of gene editing continues to evolve, scientists are looking for ways to make these custom therapies more accessible and efficient. The case of KJ Muldoon stands as a landmark example of how targeted genetic intervention can save lives and transform patient care.
Ask the Author
Subscribers can ask the journalist a question about this story. Subscribe to ask.
Neutrality note
Auto-harvested from global news wires and presented neutrally by PENN.
to vote
Comments
No comments yet — be the first to share your thoughts.
Related stories in Health and Fitness

Standing Up From a Chair Linked to Lower Mortality Risk in Older Women
2026-11-17
New Research Links Unhealthy Plant-Based Diets to Brain Structure Changes
2026-11-17
